| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
INTESTINAL MICROFLORA |
1 Department of Biochemistry and Food Chemistry, University of Turku, Finland
2 Department of Paediatrics, Tampere University Hospital, Tampere, Finland
3 Department of Paediatrics, Turku University Hospital, Turku, Finland
Correspondence to:
Correspondence to:
P V Kirjavainen, Functional Foods Forum, University of Turku, FIN-20014 Turku, Finland;
pirkka.kirjavainen{at}utu.fi
ABSTRACT
Background: Recent data have outlined a relationship between the composition of the intestinal microflora and allergic inflammation, and demonstrated the competence of probiotics in downregulation of such inflammation.
Aims: Our aims were to characterise the relationship between gut microbes and the extent of allergic sensitisation and to assess whether the efficacy of bifidobacterial supplementation in the treatment of allergy could relate to modulation of the intestinal microbiota.
Methods: This randomised study included 21 infants with early onset atopic eczema of whom eight were intolerant (highly sensitised group (HSG)) and 13 tolerant (sensitised group (SG)) to extensively hydrolysed whey formula (EHF). In the SG, six were weaned to EHF without (placebo group (PG)) and seven to EHF with Bifidobacterium lactis Bb-12 supplementation (bifidobacteria treated group (BbG)). The faecal microflora of infants in the HSG was analysed only before weaning whereas in the SG the faecal microflora was analysed both before and after weaning.
Results: Infants in the HSG had greater numbers of lactobacilli/enterococci than those in the SG. Serum total IgE concentration correlated directly with Escherichia coli counts in all infants and with bacteroides counts in the HSG, indicating that the presence of these bacteria is associated with the extent of atopic sensitisation. The effect of supplementation was characterised as a decrease in the numbers of Escherichia coli and protection against an increase in bacteroides numbers during weaning.
Conclusions: These data indicate that bifidobacterial supplementation appears to modify the gut microbiota in a manner that may alleviate allergic inflammation. Further studies are needed to confirm this conclusion.
Keywords: intestinal microflora; breast feeding; whey formula; probiotics; bifidobacteria; allergy; infants
Abbreviations: BbG, bifidobacteria treated group; EHF, extensively hydrolysed whey formula; FISH, fluorescence in situ hybridisation; HSG, highly sensitised group; IQR, interquartile range; LPS, lipopolysaccharide; PBS, phosphate buffered saline; PG, placebo group; SG, sensitised group
This article has been cited by other articles:
|
|
 |
|
  J. M. Saavedra Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action, and Practical Aspects Nutr Clin Pract, June 1, 2007; 22(3): 351 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Haarman and J. Knol Quantitative Real-Time PCR Assays To Identify and Quantify Fecal Bifidobacterium Species in Infants Receiving a Prebiotic Infant Formula Appl. Envir. Microbiol., May 1, 2005; 71(5): 2318 - 2324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Salminen, M. Gueimonde, and E. Isolauri Probiotics That Modify Disease Risk J. Nutr., May 1, 2005; 135(5): 1294 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Probiotics for atopic diseases DTB, January 1, 2005; 43(1): 6 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kaminogawa and M. Nanno Modulation of Immune Functions by Foods Evid. Based Complement. Altern. Med., December 1, 2004; 1(3): 241 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Noverr, R. M. Noggle, G. B. Toews, and G. B. Huffnagle Role of Antibiotics and Fungal Microbiota in Driving Pulmonary Allergic Responses Infect. Immun., September 1, 2004; 72(9): 4996 - 5003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Salminen, G R Gibson, A L McCartney, and E Isolauri Influence of mode of delivery on gut microbiota composition in seven year old children Gut, September 1, 2004; 53(9): 1388 - 1389. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Saavedra, A. Abi-Hanna, N. Moore, and R. H Yolken Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety Am. J. Clinical Nutrition, February 1, 2004; 79(2): 261 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Prioult, I. Fliss, and S. Pecquet Effect of Probiotic Bacteria on Induction and Maintenance of Oral Tolerance to {beta}-Lactoglobulin in Gnotobiotic Mice Clin. Vaccine Immunol., September 1, 2003; 10(5): 787 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Millar, M Wilks, and K Costeloe Probiotics for preterm infants? Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2003; 88(5): F354 - F358. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
